Bubolz, Z.M., Weissinger, S.E., Stenziger, A., et al. (2014) Potential Clinical Implications of BRAF Mutations in Histiocytic Proliferations. Oncotarget, 5, 4060-4070.

BRAF突变的结直肠癌预后及治疗研究进展
Advances in Prognosis and Treatment of Colorectal Cancer with BRAF Mutation

陈 琪, 李瑜英   

临床医学进展Vol.12 No.5, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.125659, May 27 2022

BRAF V600E在甲状腺乳头状癌临床应用性中的研究进展
Research Progress of BRAF V600E Gene Mutation in Papillary Thyroid Carcinoma

刘延泽, 刘嘉琦, 李 良   

临床医学进展Vol.12 No.9, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.1291227, September 19 2022

黑素瘤BRAF抑制剂耐药与细胞自噬的相关性
Correlation between Autophagy and Drug Resistance of Melanoma BRAF Inhibitors

刘 添, 王永晨    科研立项经费支持

临床医学进展Vol.12 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.122152, February 18 2022

61例儿童组织细胞坏死性淋巴结炎临床分析
Clinical Analysis of 61 Cases of Histiocytic Necrotizing Lymphadenitis in Children

张 雪, 王玲珍, 泥永安, 孙立荣   

临床医学进展Vol.11 No.3, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.113162, March 19 2021

BRAF V600E、p53、CD56、CK19、Galectin-3、TPO在247例甲状腺乳头状癌的表达与诊断价值
Expression of BRAF V600E, p53, CD56, CK19, Galectin-3, TPO in 247 Cases of Papillary Thyroid Carcinoma and Its Diagnostic Value

胡诗梦, 王 敏   

临床医学进展Vol.12 No.8, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.1281044, August 8 2022

FGFR突变对癌症免疫治疗和肿瘤微环境的临床意义：一项泛癌症研究
Clinical Implications of FGFR Mutations for Cancer Immunotherapy and Tumor Microenvironment: A Pan-Cancer Study

王 力, 任志旋, 冷朝晖    科研立项经费支持

临床医学进展Vol.13 No.5, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.1351081, May 16 2023